Remove Blogging Remove Pricing Remove San Diego Remove Startup
article thumbnail

San Diego Life Sciences Roundup: Evofem, Cullgen, BrainLeap & More

Xconomy

A software startup launches games that it says may help children with disorders that cause attention difficulties. Get the details on these developments and more in San Diego life sciences news: —Evofem Biosciences (NASDAQ: EVFM ) struck a deal to raise up to $80 million in a private placement. million shares.

article thumbnail

Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout

Xconomy

There’s nothing abstract about a 20 percent jump in a company’s stock price. But yeah, that happened to Loxo Oncology when it released data previews for its American Society for Clinical Oncology presentations; the meeting starts in two weeks in Chicago. Read more » Reprints | Share:

Pricing 62
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More

Xconomy

Pharmaceutical companies typically raise prescription drug prices at the start of each year and this year was no different. The increases were the latest reminder that, despite President Trump’s fiery campaign rhetoric, the administration had done little to actually lower drug prices.

Pricing 84
article thumbnail

After Trump Sounds Off, Senate Has Adult Conversation on Drug Prices

Xconomy

In advance of an anticipated Senate hearing on drug prices, President Donald Trump once again denounced drug companies as “getting away with murder.” He also said at the time that “we’re going to start bidding,” a reference to Medicare’s inability to negotiate drug prices.

Pricing 56
article thumbnail

UPS Takes Minority Stake in Self-Driving Truck Startup TuSimple

Xconomy

TuSimple, an autonomous trucking company, has been conducting test drives for UPS between the Arizona cities of Phoenix and Tucson since May.

article thumbnail

Bio Roundup: POTUS on Prices, a16z’s Fund, Aimmune’s Approval & More

Xconomy

The president’s State of the Union address was wide-ranging, as they tend to be, but those who tuned in heard mention of two hot health policy topics: price transparency and drug pricing reform.

Pricing 61
article thumbnail

Agbio Startup Cibus Files for an IPO to Support Gene-Editing R&D

Xconomy

The San Diego-based biotech set a preliminary $100 million target for its IPO in documents filed with securities regulators Friday. That figure will change as the company determines how many shares it will sell and at what price. Cibus has applied for a listing on the Nasdaq exchange under the stock symbol “CBUS.”